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Abstract
The identification of secreted factors that can selectively stimulate the generation of insulin producing b-cells from stem
and/or progenitor cells represent a significant step in the development of stem cell-based b-cell replacement therapy. By
elucidating the molecular mechanisms that regulate the generation of b-cells during normal pancreatic development such
putative factors may be identified. In the mouse, b-cells increase markedly in numbers from embryonic day (e) 14.5 and
onwards, but the extra-cellular signal(s) that promotes the selective generation of b-cells at these stages remains to be
identified. Here we show that the retinoic acid (RA) synthesizing enzyme Raldh1 is expressed in developing mouse and
human pancreas at stages when b-cells are generated. We also provide evidence that RA induces the generation of Ngn3
+
endocrine progenitor cells and stimulates their further differentiation into b-cells by activating a program of cell
differentiation that recapitulates the normal temporal program of b-cell differentiation.
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Introduction
The identification of secreted signal(s) that promotes the
selective generation of b-cells from stem and/or progenitor cells
represent a significant step in the development of stem cell-based
b-cell replacement therapy for type 1 diabetes. Such signals may
be identified by studying how b-cells are normally generated
during pancreas development. Transcription factors with impor-
tant roles during pancreatic development and endocrine cell
differentiation have been identified, and Notch signaling has been
shown control pancreatic cell differentiation by regulating the
expression of the proendocrine gene Neurogenin 3 (Ngn3) [1–6]. In
contrast, no secreted signal has been identified that selectively
promotes the generation of b-cells during pancreas development.
Ngn3
+ endocrine progenitor cells give rise to different endocrine
cell types at different stages of mouse embryonic development
[1,2,5]. Glucagon positive (Glu
+) cells appear by embryonic day (e)
,9.5 whereas insulin positive (Ins
+) cells appear predominantly
from ,e14.5 and onwards. Between e14.5 and neonatal stages
Ins
+ cell numbers increase 4–10 fold more than other pancreatic
endocrine cell types [7,8]. Why Ngn3
+ endocrine progenitor cells
preferentially start to differentiate into Ins
+ cells at ,e14.5 remains
unknown. One possibility is that a cell intrinsic program in Ngn3
+
progenitor cells regulates the temporal order of generation of
differentiated endocrine cell types. Alternatively, extra-cellular
signals may induce distinct classes of Ngn3
+ endocrine progenitor
cells at different developmental stages.
The vertebrate ventral spinal cord is a well studied system with
respect to the mechanisms by which different classes of progenitor
cells and differentiated progeny, inter-neurons and motor neurons,
are generated [9–11]. Pancreatic endocrine cells and neurons
share many common features and in particular b-cells and spinal
cord motor neurons show striking similarities in patterns of gene
expression of several basic-helix-loop-helix (Bhlh) and homeodo-
main transcription factors [11–13]. The secreted signal retinoic
acid (RA) has been shown to control multiple, sequential steps of
motor neuron differentiation in the ventral spinal cord, including
initial patterning of progenitors cells and specification of motor
neuron subtype identity [11]. The similarities between b-cells and
motor neurons suggest that RA may also control specification
and/or differentiation of insulin-producing b-cells.
Here we show that RA receptor signalling is required in early
pancreatic progenitor cells for pancreatic development. We also
show that the RA-synthesizing enzyme Raldh1 is expressed at
stages when b-cells are normally generated in embryonic mouse
and human pancreas. Using an explant assay of pancreatic
endocrine cell differentiation, we provide evidence that RA
promotes both the generation of Ngn3
+ endocrine progenitor
cells and their further differentiation into b-cells. The identifica-
tion of a secreted signal that induces the generation insulin
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2841producing b-cells will aid in the establishment of a stem cell-based
therapy for type 1 diabetes.
Results
Raldh1 expression coincides with b-cell differentiation in
both mouse and human fetal pancreas
To address a potential role for RA in generation of endocrine
progenitor and/or b-cells we first investigated expression of
Retinaldehyde dehydrogenase (Raldh) genes in the developing mouse
pancreas by in situ hybridization. Neither Raldh 3 nor 4 was
expressed in the developing pancreatic epithelium or mesenchyme
at any stage examined (data not shown). Although Raldh2 was
expressed in e8.0 somitic mesoderm and e10.5 duodenal
mesenchyme (Fig. S1a), it was not expressed within the developing
pancreas. Raldh1 was, however, expressed in the pancreatic
epithelium from ,e13.5 and onwards (Fig. 1a), coinciding with
the period of massive b-cell differentiation. Expression of Raldh1 in
embryonic mouse pancreas was restricted to the branching ductal
and acinar epithelium flanking the differentiating endocrine cells
(Fig. S1b). qRT-PCR revealed that RALDH1 expression over-
lapped temporally with that of INSULIN also in the developing
human pancreas, whereas expression of RALDH 2, 3, and 12 (the
homolog of mouse Raldh4) was distinctly lower and/or barely
detectable (Fig. 1b and data not shown). In situ hybridization
analyses confirmed expression of RALDH1 in fetal human
pancreas (Fig. 1c). Thus, the expression of the RA-synthesizing
enzyme Raldh1, coincides with the period of b-cell differentiation
in both mouse and human pancreatic development.
RA-signalling is required for pancreatic development
To address the role for RA-signalling in the developing pancreas
we next generated transgenic (tg) mice expressing a dominant-
negative (dn) form of the retinoic acid receptor (RAR) a, denoted
RAR403 [14,15], under the control of the Ipf1/Pdx1 promoter,
which is active both in pancreatic progenitor cells and in b-cells
[16]. The resulting Ipf1/RAR403 tg mice showed complete
pancreatic agenesis, lacking both dorsal and ventral pancreas, and
died at the neonatal stage (Fig. 1d). These data are consistent with
Raldh2 expression in lateral plate and somitic mesoderm of e8.0
mouse embryos (Fig. S1a) and provides support for an intrinsic role
for RA-signalling in specified Ipf1/Pdx1
+ pancreatic progenitor
cells. The perturbation of both dorsal and ventral pancreatic
development in Ipf1/RAR403 tg mice contrasts with the Raldh2
2/2
mutant mice in which dorsal but not ventral pancreatic develop-
ment was affected [17,18]. Taken together, our data provide
evidence for a requirement for RA-signalling in early pancreatic
progenitor cellsof both thedorsaland ventral pancreaticanlage and
suggest the existence of a Raldh2 independent source of RA that
signals to the ventral pancreatic anlage.
Retinoic acid promotes the generation b-cells
The impaired pancreatic development in Ipf1/RAR403 tg mice
precluded any analysis of a role for RA-signalling in b-cell
differentiation, and attempts to block RA signalling in b-cells by
expressing the dnRARa in b-cells of tg mice using the rat insulin 1
promoter
19 failed to generate tg offspring, which may be due to
non-pancreatic expression of the transgene at embryonic stages
[20]. The elucidation of the roles of RA in motor neuron
generation benefited largely from the use of an ex vivo explant
system [9,21]. Thus, to assess a potential role for RA signalling in
b-cell generation we established an ex vivo explant system where
e10.5 dorsal pancreatic buds were cultured in serum-free, defined
media for six days in presence or absence of RA. Using these
culture conditions the explants survive but do not grow.
In explants cultured for six days in absence of RA, only a few
glucagon positive (Glu
+) and insulin positive (Ins
+) cells were
observed and the majority of cells were of non-endocrine identity
(Fig. 2a,b and data not shown). In explants cultured in presence of
25nM RA a .3-fold increase in the relative number and ,2,5 fold
increase in absolute numbers of Ins
+ cells (67633 Ins
+ cells in
control explants and 155623 Ins
+ cells in RA treated explants,
presented as mean6S.E.M) was observed, whereas there was no
significant increase in the number of Glu
+ cells (Fig. 2a,b and data
notshown). Higher concentrations of RA (50and 100 nM), failed to
further stimulate the generation of Ins
+ cells, and even showed an
inhibitory effect on endocrine cell differentiation (data not shown).
The expression of Raldh1 in the developing pancreatic
epithelium (Fig. 1a–c) suggests that the epithelial cells themselves
Figure 1. Raldh1 expression in mouse and human embryonic
pancreas. (A) In situ hybridization of an e13.5, e14.5 and e15.5 mouse
pancreas using a Raldh1 probe. (B) qRT-PCR using cDNA prepared from
human fetal pancreas (n=3 for week 8, 9, 10, 11, 13, 14 and 18, n=2 for
week 12, 15, 17 and 21, n=1 for week 19 and 20) with RALDH1 and
INSULIN specific primers. (C) In situ hybridizations of week 12, week 14
and week 17 human fetal pancreas using a RALDH1 probe. (D) The
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+ cells.
Previous studies have, however, shown that explants grown in
medium are deprived of both RA and the metabolic substrate
required for synthesis of RA by RA-synthesizing enzymes [21].
Thus, to test for RA-synthesizing activity in the pancreatic
explants the RA precursor retinol was added to the medium. In
explants cultured in presence of 5 mM retinol or 100 nM retinol a
,10-fold increase in Ins
+ cells was observed as compared to that of
control explants (Fig. 2d and data not shown). Taken together,
these results support the existence of an endogenous RA
synthesizing system in the developing pancreas that promotes
the generation of ins
+ cells from pancreatic progenitor cells.
Retinoic acid induces the expression of transcription
factors that control endocrine cell differentiation
In the ventral spinal cord RA induces a transcriptional program
that culminates in the generation of a distinct set of motor neurons
[9–11]. To begin to understand how RA promotes the generation
of Ins
+ cells in our explant system, we analyzed expression of
transcription factors that regulate endocrine cell differentiation.
Pancreatic endocrine cell differentiation, including that of b-cells,
is preceded by and dependent on transient expression of the pro-
endocrine gene Ngn3 in progenitor cells [1–6]. Moreover, during
motor neuron differentiation RA has been shown to regulate the
expression of the pro-neural gene Ngn2 [9–11]. Thus, we
examined Ngn3 expression in explants harvested after 2 or 4
days of in vitro culture in presence or absence of RA. After 2 days of
culture, explants exposed to RA showed a ,4-fold increase in both
relative (Fig. 3a,b) and absolute number of Ngn3
+ cells (2468
Ngn3
+ cells in control explants and 94624 Ngn3
+ cells in RA
treated explants, presented as mean6S.E.M) compared to
controls. Consistent with the transient role for Ngn3 in pancreatic
endocrine progenitor cell differentiation [1–6], the number of
Ngn3
+ cell was not significantly greater than that in control
explants after an additional 2 days of RA exposure (Fig. 3b).
Ngn2 expression and thus motor neuron differentiation
critically depends on the transient expression of Olig2, a Bhlh
transcriptional repressor, induced by RA [9–11]. To elucidate
whether expression of Olig2 or related Bhlh factors [22,23]
correlated with Raldh1 expression in the pancreas we investigated
expression of Olig1-3, and Bhlhb2-5 in e13.5 and e15.5 pancreas by
qRT-PCR. Only Bhlhb2 was robustly expressed in the e13.5 and
e15.5 pancreas (Fig. S2 and data not shown) and its expression was
also increased by ,50% in RA-treated explants at day 2 of culture
(Fig. 3c). NeuroD is a Ngn3 target gene that is expressed in
differentiated endocrine but not pro-endocrine cells. In agreement
with the normal temporal order of expression of Ngn3 and NeuroD,
no increase in NeuroD expression was observed at day 2 of RA
exposure whereas an almost 3-fold increase in NeuroD expression
was evident at day 4 of RA exposure (Fig. 3c). Thus, RA triggers
the expected temporal sequence of events of transient Ngn3
expression followed by increased NeuroD expression.
During pancreatic and motor neuron development, activation
of Notch results in increased expression of Hes genes that repress
expression of the proendocrine gene Ngn3 and the pro-neural gene
Ngn2, respectively, thus maintaining cells as undifferentiated
progenitor cells [12,13]. Bhlhb2 has been shown to inhibit Notch
mediated activation of the Hes1 promoter by interacting with the
intracellular form of Notch [24]. In agreement with the increased
expression of Bhlhb2 in RA treated explants at day2, Hes1
expression was reduced by RA to only ,50% of that of untreated
controls at day 4 (Fig. 3c). Thus, sequential stimulation of Bhlhb2,
Ngn3, and NeuroD expression, paralleled by reduced Hes1
expression, precedes RA-stimulated differentiation of b-cells.
Sequential roles for RA in the generation of b-cells
The induction of Ngn3
+ endocrine progenitor cells and the
preferential generation of b-cells by RA, suggests that RA may
promote the generation of a set of Ngn3
+ cells that consequently
are destined to generate b-cells. Alternatively, similar to its role
Figure 2. RA stimulates b-cell differentiation in vitro. (A) Representative sections of control and RA-treated e10.5 dorsal pancreatic explants
cultured for 6 days and analyzed for insulin (green) and glucagon (red) expression. (B) Quantification of insulin and glucagon positive cells in control
pancreatic explants and pancreatic explants exposed to RA for 6 days (n=6 for both) displayed as % positive cells/total number of cells. (C)
Representative sections of control and retinol-treated e10.5 pancreatic explants cultured for 6 days and stained with antibodies against insulin
(green). (D) Quantification of insulin expression in control and retinol-treated pancreatic buds (n=2 for both). Scale bar=40 mMi n( A) and 30 mMi n
(C). Data show mean6S.E.M, *p,0.05.
doi:10.1371/journal.pone.0002841.g002
RA Promotes b-Cells
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sequential functions during the generation of b-cells, i.e. inducing
both Ngn3 expression and the further differentiation of Ngn3
+
cells into b-cells. To distinguish between these two possibilities,
e10.5 pancreatic buds were cultured in presence of RA for only the
first 2 or 4 days of the total 6 day culture period. No significant
increase in the number of Ins
+ cells was observed in explants
exposed to RA for only the first 2 of the total 6 day culture period
(Fig. 4a). In explants exposed to RA for the first 4 of the total 6
days, there was a significant increase in the number of Ins
+ cells
(Fig. 4a), though smaller than that observed in explants exposed to
RA the entire 6 day culture period (Fig. 2b and data not shown).
Thus, RA needs to be added throughout the culture period to
ensure Ins
+ cell differentiation.
Like the sequential expression of Bhlh genes (Fig. 3c),
homeobox genes linked to b-cell differentiation were expressed
in a sequential manner during RA-stimulated Ins
+ cell differen-
tiation. The expression of Pax4, a critical factor in specification of
b-cell identity [25], was not significantly increased after 2 days of
RA exposure but a ,2.5 fold increase in Pax4 expression was
observed after 4 days of RA exposure (Fig. 4a). The Ins
+ cells
induced by RA expressed the additional b-cell markers Ipf1/Pdx1,
Nkx6.1 and Hb9, as well as C-peptide and Glut2, after 6 days of
RA exposure (Fig. 4b and data not shown). RA therefore mediates
sequential induction of the Bhlh transcription factors Ngn3, Bhlhb2,
and NeuroD that promote the generation of endocrine cells,
followed by induction of the homeobox gene, Pax4, that
determines b-cell identity, and finally the generation of insulin
producing b-cells that express the homeodomain proteins Ipf1/
Pdx1, Nkx6.1 and Hb9 (Fig. 4c). Taken together these results
provide evidence that, in analogy with the generation of motor
neurons in the spinal cord, RA acts at multiple levels in the
generation of b-cells in the pancreas.
Discussion
In the developing mouse pancreas, b-cells increase in large
numbers from ,e14.5 onwards, suggesting that intrinsic and/or
extrinsic signals favour b-cell differentiation at these stages.
Transcription factors that control specification of pancreatic
endocrine progenitor cells and their further differentiation into
b-cells have been identified [13]. In contrast, secreted signals that
may promote the large increase in generation of b-cells remain to
be identified. In this study, we show that the RA synthesizing
enzyme Raldh1 is expressed in the developing mouse and human
pancreas at stages when b-cells are predominantly generated.
Moreover, using an explant assay of pancreatic endocrine cell
differentiation, we provide evidence that RA activates a program
of cell differentiation that recapitulates the normal temporal
program of b-cell differentiation.
In Raldh2 mutant mice, Ipf1/Pdx1 expression is lost in the
dorsal but not ventral pancreatic bud and mutant mice present
with dorsal but not ventral pancreatic agenesis [17,18]. However,
the dorsal but not ventral pancreatic mesenchyme fails to form in
Raldh2 mutants [17], suggesting that this phenotype is indirect.
Consistent with this possibility early pancreatic markers such as
Hb9 and Isl1 are expressed in e9.5 Raldh2 mutant dorsal
pancreatic endoderm [17]. Moreover, maternal RA administra-
tion restored the formation of dorsal pancreatic mesenchyme,
Ipf1/Pdx1 expression and thus pancreatic development in Raldh2
mutant embryos [17]. Loss of dorsal pancreatic mesenchyme and
Ipf1/Pdx1 expression are also observed in Isl1 [26] and N-cad [27]
mutant embryos, and dorsal pancreatic development could be
rescued in both mutants by co-culturing the pancreatic endoderm
with wild-type mesenchyme [26,27]. In Xenopus and zebrafish,
induction of pancreatic development is inhibited following
treatment of early, pre-pancreatic embryos, with the RA-
antagonist BMS493, and embryos treated with exogenous RA
prior to the initiation of the pancreatic development show ectopic
expression of pancreatic markers such as insulin [28–31].
Collectively, these data provide evidence that RA is required
during early (dorsal) pancreas development, at least in part by
promoting the development of dorsal pancreatic mesenchyme. In
addition, the apancreatic phenotype of Ipf1/RAR403 tg mice
suggests a direct role for RA signaling in both the early dorsal and
ventral pancreatic epithelium after the onset of Ipf1/Pdx1
expression. The lack of pancreas in these mice unfortunately
precluded the establishment of a transgenic line that would allow
detailed analysis of the pancreatic developmental defect.
Differentiation of all pancreatic endocrine cells requires the
transient activity of the proendocrine gene Ngn3 in progenitor cells
[1–6]. Different classes of endocrine cells are generated at different
Figure 3. RA induces Ngn3 expression in vitro. (A) Representative
sections of a control and RA-treated e10.5 dorsal pancreatic explants
cultured for 2 days and stained with antibodies specific for Ngn3. (B)
Quantification of Ngn3
+ cells in control and RA-treated explants
cultured for 2 or 4 days (n=4 for each condition) displayed as %
Ngn3 expressing cells/total number of cells. (C) qRT-PCR using Bhlhb2,
Hes1 and NeuroD specific primers on cDNA from control and RA treated
e10.5 pancreatic explants cultured for 2 (n=13) or 4 days (n=9). Data
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expression of Ngn3 in early pancreatic progenitor cells generates
predominantly glucagon-producing cells whereas later induction
generates b-cells and other endocrine cell types [1,2,5]. Our data
show that the temporal expression of the RA-synthesizing enzyme
Raldh1 in the developing pancreas coincides with the large increase
in b-cells from ,e14.5 and onwards. Using an explant assay, we
also show that RA and RA precursors selectively stimulate b-cell
differentiation, resulting in both a relative and absolute increase in
b-cell numbers. Raldh1 mutant mice have been generated and are
viable, suggesting that they are not devoid of b-cells [32]. Whether
this reflects increased expression of any of the other Raldhs in the
pancreas of Raldh1 mutant mice at the time of b-cell differentiation
will have to await future analyses of Raldh2-4 expression in
Raldh1
2/2 mice. An alternative, RALDH-independent mode of
RA synthesis mediated by Cyp1b1 was recently reported [33] and
qRT-PCR analyses detected low level expression of Cyp1b1 in
mouse e13 and e15 pancreas and in 8–19 weeks human fetal
pancreas (data not shown).
By using medium containing high levels of serum that favors
growth of explants, previous studies suggest that RA antagonizes
growth and exocrine cell differentiation leading to a relative but
not absolute increase of b-cells [34,35]. In the developing
pancreas, Fibroblast growth factor (FGF) signals provided by the
mesenchyme stimulate growth and differentiation of the exocrine
pancreas [30,36,37]. RA and FGFs are known to exert opponent
activities [38] and under culture conditions promoting growth, RA
is likely to primarily antagonize the stimulatory effect of FGFs on
growth and differentiation of the exocrine pancreas. In support of
this, FGF10 was shown to antagonize the negative effects of RA on
pancreatic growth, morphogenesis, and exocrine differentiation
[34]. b-cell differentiation in the mouse embryo becomes
prominent when the mesenchyme/epithelium ratio, and thus
growth decreases [7,8]. This phase, sometimes referred to as the
secondary transition [7], coincides temporally with Raldh1
expression in the pancreas. Our culture conditions were designed
to mimic this phase of b-cell differentiation by using defined,
minimal media without serum, which allows survival but not
growth of the pancreatic explants. Under these conditions, RA or
RA precursors selectively stimulate differentiation of pancreatic
progenitors into b-cells.
Together, our results provide strong evidence that RA promotes
both the generation of Ngn3
+ endocrine progenitor cells and their
further differentiation into b-cells. The increase in Ngn3
+ cells is
Figure 4. Temporal changes in the expression of Bhlh and homeobox genes in response to RA. (A) Quantification of Ins
+ cells in control
pancreatic explants (n= 6) and pancreatic explants exposed to 25 nM RA for the first 2 (n=3) or 4 days (n=4) of the 6 day in vitro culture period
displayed as % positive cells/total number of cells. Data show mean6S.E.M, *p,0.05 **p,0.01. (B) qRT-PCR using Pax4 specific primers on cDNA
from control and RA treated e10.5 pancreatic explants cultured for two (n=13) or four days (n=9). Data represent the mean value6S.E.M. *p,0.05,
**p,0.01. (C) 6d RA treated explants double-stained for insulin (green) and Ipf1/Pdx1, Nkx6.1, Hb9 or C-peptide (all red). (D) Schematic model
summarizing the multiple proposed roles of RA during pancreatic development. Our data provides evidence that RA sequentially specifies: i)
proendocrine cells; ii) committed pre-b-cells; and finally iii) differentiated b-cells. Scale bar=30 mMi n( C) (7,5 mM for the enlarged inserts).
doi:10.1371/journal.pone.0002841.g004
RA Promotes b-Cells
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expression is significantly reduced first after 4 days of RA
exposure, leaving open the possibility that the increase in Ngn3
+
cells is independent of Hes1 expression. Whether the early increase
in Bhlhb2 expression already at day 2 of RA exposure, directly or
indirectly, promotes a parallel increase in Ngn3 expression, similar
to the positive effects of Olig2 on Ngn2 expression [9.11], will
require further analyses. Nevertheless, the early increase in the
expression of Bhlhb2, which has Notch antagonizing activity [24],
is in agreement with the subsequent reduced expression of Hes1
observed at day 4 of RA exposure. The identification of RA as a
secreted signal that promotes the selective generation of b-cells,
and increased availability of human ES cell lines that respond to
experimental protocols that allow efficient and reproducible
generation of pancreatic endoderm, will help to develop stem
cell-based b-cell replacement therapy.
Materials and Methods
Human fetal pancreas isolation
The fetal pancreatic studies were approved by the Human
Subject Research Office, Miami, Florida, in compliance with US
legislation and the guidelines of our institution. Fetal pancreatic
tissue was obtained following written maternal consent. Elective
termination of pregnancy was performed by aspiration between 8
and 19 weeks of development. Warm ischemia lasted less than
30 minutes.
Animals and generation of transgenic mice
Animal studies were approved by the Institutional Animal Care
and Use Committee of Umea ˚ University and conducted in
accordance with the Guidelines for the care and use of Laboratory
Animals. Human RARa403 was subcloned behind the Ipf1/Pdx1
promoter and the RIP promoter respectively. Transgenic mice
were generated as described
16.
Immunohistochemistry and in situ hybridization
Immunohistochemical analyses were carried out as described
elsewhere
16. Primary antibodies used were: rabbit anti-Ipf1
39
(Ohlsson et al., 1993), rabbit anti-Ngn3
40, guinea pig anti-Insulin
(Linco), rabbit anti C-peptide (Linco), rabbit anti-Glucagon
(Linco), rabbit anti-Nkx6.1 (raised against a GST-Nkx6.1 fusion
protein by AgriSera AB, Va ¨nna ¨s, Sweden) and rabbit anti-Hb9
(kindly provided by T. M. Jessell). Secondary antibodies were: Cy3
anti-rabbit (Jackson), Alexa Fluor 488 anti-guinea pig and Alexa
Fluor 594 anti-rabbit (Molecular Probes). In situ hybridizations
were performed as previously described
16. Images were acquired
using a Zeiss Axioplan imaging microscope or a Nikon confocal
microscope C1 fitted with an Ar, He/Ne and a blue diode laser.
Digitalized confocal images were assigned red and green
pseudocolors for Cy3 and Alexa Fluor 488 respectively.
In vitro cultures
Isolated e10.5 dorsal pancreatic buds were cultured on filters
(Millipore) in 24-well plates (Costar) with 400 ml of medium
consisting of DMEM-glutamax1 (Gibco), 16N2-supplement
(Gibco) and pen/strep (Gibco), and different concentrations of
all trans retinoic acid or retinol (Sigma). Explants were cultured for
up to six days in 37uC and 5% CO2 and medium was changed
every other day. After culture, explants were washed twice in PBS,
fixated in 4% PFA at 4uC for 20 minutes followed by two more
washes in PBS. Explants were frozen in drops of Tissue Tek OCT
applied on glass slides (Menzel) and stored at 280uC until
sectioned (8 mm sections) and analyzed by immunohistochemistry.
Quantification of mRNA expression levels
cDNA was prepared from explants, fetal mouse and human
pancreas and qRT-PCR analysis of the cDNA was performed
essentially as described
41. Expression of TATA box binding
protein (TBP) and human 18S ribosomal RNA (18S) was used to
normalize expression levels. Primer sequences are found in
Supplementary Table S1.
Statistical analysis
All data is presented as mean value6standard errors (S.E.M.).
All statistical analyses were performed using the two-tailed, two
sample Students t-test and P values ,0.05 were considered as
significant.
Supporting Information
Figure S1 RALDH1 and 2 expression in mouse embryos
Found at: doi:10.1371/journal.pone.0002841.s001 (1.37 MB TIF)
Figure S2 Bhlhb2 and Ngn3 expression in e13.5 mouse
pancreas.
Found at: doi:10.1371/journal.pone.0002841.s002 (6.05 MB TIF)
Table S1 Primer sequences.
Found at: doi:10.1371/journal.pone.0002841.s003 (0.04 MB
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